PIN Pharma logo — A pioneering biopharmaceutical firm dedicated to creating br...

PIN Pharma

A pioneering biopharmaceutical firm dedicated to creating broad-based immuno-modulatory therapies by synergizing the innate and adaptive immune systems.

Founded 2011 Series A Total: $6.75M Biotechnology, Pharmaceutical

General Information

Company Name PIN Pharma
Founded Year 2011
Industries Biotechnology, Pharmaceutical
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with PIN Pharma. To contact PIN Pharma, visit pinpharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does PIN Pharma compare?

A PDF of PIN Pharma and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting PIN Pharma soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About PIN Pharma

PIN Pharma is a pioneering biopharmaceutical firm dedicated to creating broad-based immuno-modulatory therapies by synergizing the innate and adaptive immune systems. Established in 2011, the company is a venture-backed research and development entity specialized in immunotherapies, with a primary focus on oncology. However, its technology holds promise for applications in various other disease areas. The latest significant funding for PIN Pharma was a $6.75M Series A investment in January 2014, led by NGN Capital. The firm's innovative method for linking the innate and adaptive immune systems is at the core of its dedication to developing ground-breaking therapies with broader applications throughout the field of biotechnology and pharmaceuticals.

Business keywords: biopharmaceutical, immunotherapy, oncology, innovative technology, venture-backed, immune system modulation, therapeutic applications, private company, biomedical research, immunomodulation, cancer treatment, immune response, therapeutic innovation, disease areas

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $6.75M 1
NGN Capital
01 Jan 2014

PIN Pharma Alternatives & Competitors

View All Alternatives
PIN Pharma vs
Simcha Therapeutics
Simcha Therapeutics United States

Overcoming biological challenges in clinically translatable pathways.

Series B
15 employees
Biotechnology, Health and Wellness
PIN Pharma vs
Elicio Therapeutics
Elicio Therapeutics United States

Lymph-Node Targeted Immunotherapies

IPO
47 employees
Biotechnology, Health Care
PIN Pharma vs

Science for cure.

Grant
28 employees
Biotechnology, Health Care

FAQ About PIN Pharma

A pioneering biopharmaceutical firm dedicated to creating broad-based immuno-modulatory therapies by synergizing the innate and adaptive immune systems.
PIN Pharma was founded in 2011.
PIN Pharma operates in Biotechnology and Pharmaceutical. Its work centres on biopharmaceutical, immunotherapy, oncology and innovative technology.
PIN Pharma has completed 1 funding round, raising a total of $6.75M. The latest funding stage is Series A.
Top alternatives and competitors to PIN Pharma include Simcha Therapeutics, Elicio Therapeutics, NEOGAP Therapeutics AB, Janux Therapeutics, OSE Immunotherapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
PIN Pharma and Simcha Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for PIN Pharma, https://bouncewatch.com/company/pin-pharma, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes